590 related articles for article (PubMed ID: 19685467)
1. Perspective: A tale of 'cautious pessimism': Biotechnology, recession and the 'new economy'.
Kewell B; Webster A
Biotechnol J; 2009 Aug; 4(8):1106-8. PubMed ID: 19685467
[No Abstract] [Full Text] [Related]
2. The biotechnology industry: What's next?
Guertin PA
Biotechnol J; 2009 Aug; 4(8):1124-31. PubMed ID: 19685466
[No Abstract] [Full Text] [Related]
3. BTJ Forum: Biotech in the financial crisis.
Biotechnol J; 2009 Aug; 4(8):1108-10. PubMed ID: 19685461
[No Abstract] [Full Text] [Related]
4. White biotech and the financial crisis.
Rabinovich M
Biotechnol J; 2009 Aug; 4(8):1117-23. PubMed ID: 19685465
[No Abstract] [Full Text] [Related]
5. Perspective: Biotech funding trends: Insights from entrepreneurs and investors.
Gruber AC
Biotechnol J; 2009 Aug; 4(8):1102-5. PubMed ID: 19685460
[TBL] [Abstract][Full Text] [Related]
6. Editorial: Biotech in the financial crisis.
Jungbauer A
Biotechnol J; 2009 Aug; 4(8):1095. PubMed ID: 19685457
[No Abstract] [Full Text] [Related]
7. Biotechnology: delivering on the promise.
Greenwood JC
Sci Transl Med; 2010 Jan; 2(13):13cm1. PubMed ID: 20371460
[TBL] [Abstract][Full Text] [Related]
8. A modest proposal: toward improved access to biotechnology research tools by implementing a broad experimental use exception.
Hoffman DC
Cornell Law Rev; 2004 May; 89(4):993-1043. PubMed ID: 15174465
[No Abstract] [Full Text] [Related]
9. European exploitation of biotechnology-do government policies help? A recent survey of public spending on biotechnology in Europe suggests that money alone cannot stimulate growth of the sector.
Senker J; Enzing C; Joly PB; Reiss T
Nat Biotechnol; 2000 Jun; 18(6):605-8. PubMed ID: 10835596
[No Abstract] [Full Text] [Related]
10. The changing norms of the life sciences.
Shorett P; Rabinow P; Billings PR
Nat Biotechnol; 2003 Feb; 21(2):123-5. PubMed ID: 12560827
[No Abstract] [Full Text] [Related]
11. Public biotechnology 2002--the numbers.
Lähteenmäki R; DeFrancesco L
Nat Biotechnol; 2003 Jun; 21(6):607-12. PubMed ID: 12776143
[No Abstract] [Full Text] [Related]
12. Materials exchange deal meager boost to India's biotech.
Jayaraman KS
Nat Biotechnol; 2005 Sep; 23(9):1031. PubMed ID: 16151380
[No Abstract] [Full Text] [Related]
13. New Zealand launches biotech seed fund.
Griggs K
Nat Biotechnol; 2004 Apr; 22(4):480-1. PubMed ID: 15085809
[No Abstract] [Full Text] [Related]
14. How the US government can fund your company.
Basu P
Nat Biotechnol; 2004 Apr; 22(4):482-6. PubMed ID: 15085814
[No Abstract] [Full Text] [Related]
15. The development of China's medical biotech industry needs to be driven by innovation.
Yu Z; Dai Y
Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752
[TBL] [Abstract][Full Text] [Related]
16. Biotech sector ponders potential 'bloodbath'.
Mitchell P
Nat Biotechnol; 2009 Jan; 27(1):3-4. PubMed ID: 19131974
[No Abstract] [Full Text] [Related]
17. Changing university roles in the century of biotechnology.
Meagher LR; Bolivar F
Nat Biotechnol; 1998 Jul; 16(7):598-9. PubMed ID: 9661170
[No Abstract] [Full Text] [Related]
18. Biotechnology and sustainability: the role of transatlantic cooperation in research and innovation.
Aguilar A; Bochereau L; Matthiessen-Guyader L
Trends Biotechnol; 2008 Apr; 26(4):163-5. PubMed ID: 18295918
[TBL] [Abstract][Full Text] [Related]
19. OECD says industrial biotech not realizing potential.
Niiler E
Nat Biotechnol; 2001 Jun; 19(6):493-4. PubMed ID: 11385413
[No Abstract] [Full Text] [Related]
20. Strategic rethink for German biotechnology.
Fernandes M; Miska D
Nat Biotechnol; 2002 Oct; 20(10):970-1. PubMed ID: 12355106
[No Abstract] [Full Text] [Related]
[Next] [New Search]
